SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : DAVID SIRK's VALUE MOMENTUM PLAYS -- Ignore unavailable to you. Want to Upgrade?


To: David Sirk who wrote (2878)6/2/1999 7:05:00 PM
From: PROFIT-TAKER  Read Replies (1) | Respond to of 4828
 
EYDY- CLOSED AT $1.21 (AFTER HOURS) Strong Buy Recommendation / Eye Dynamics .Eye Dynamics has a patented "goggle type" device which measures
important human eye movements used in the diagnosis of alcohol or drug
impairment. This infrared device, called EPS-100 was invented by Eye
Dynamics, and the company is the leading Infrared / Video-based
technology impairment testing device manufacturer in the world.

Thomas Loyd, editor of Investors' Alert, stated, "The significance to
having this device is demand has already started flowing in from the
U.S. Government, states and private companies to have this device for
drug testing transportation workers, military, corrections and more.
Also, private companies are looking at this device for use in
on-the-job accidents to minimize exposure in lawsuits."

Thomas Loyd believes the law enforcement market and the
corporate/industrial market alone is $3 billion, not to mention
schools, government agencies, transportation and correctional
organizations.

He stated, "There are very few shares outstanding, Eye Dynamics has a
patent on this device and the EPS-100 is, according to a Feb. 11 press
release issued by Eye Dynamics, the best performing device of its kind
in a government-funded study."

Eye Dynamics sells each device for approximately $15,000, which gives
the company significant profit on these devices.

Thomas Loyd again stated, "We wanted to see this stock break out to
the up-side before making a buy recommendation, which it did yesterday
on high volume; now our target is $3 or higher, short term, but it
should keep going to over $5 if the volume stays strong. At $5 it would
not be overpriced, in our opinion, given the potential of the company.
Watch this stock carefully today; if it breaks over $2, it could go on
to $3 or higher quickly."

The company has a web site at edi-vng.com or call
310/328-0477 for more information.


Shares Outstanding- 9,100,000
Float (est.)- 2,100,000
52 Week High/Low- 0.13 - 1.15
4 mo. Target- 5 1/2